FDA Adverse Event Injury Summary report: N

TOTAL ASR ACET IMP SIZE 48

MDR report key: 3020515 · Received March 26, 2013

Report

Report Number
1818910-2013-03583
Event Type
Injury
Date Received
March 26, 2013
Date of Event
October 24, 2012
Report Date
August 7, 2015
Manufacturer
DEPUY INTL., LTD. - 8010379
Product Code
KWA
Removal / Correction Number
Z- 1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4).DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA. (B)(4).

Description of Event or Problem · 1

ASR REVISION.ASR XL ACETABULAR SYSTEM - LEFT.REASON(S) FOR REVISION: PAIN.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4). REASON FOR ORIGINAL COMPLAINT: ASR REVISION. ASR XL ACETABULAR SYSTEM - LEFT. REASON(S) FOR REVISION: PAIN. BILATERAL PATIENT. SEE (B)(4) FOR RIGHT HIP. UPDATE 10 AUGUST 2015: SEE (B)(4) FOR RIGHT HIP. UPDATED TO LEGAL. UPDATED DOI TO (B)(6) 2010. ADDED MANUFACTURE AND EXPIRY DATES FOR PRODUCTS. TAKEN FROM KENNEDY ALERT 7 AUGUST 2015.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
123869 TOTAL ASR ACET IMP SIZE 48 HIP ACETABULAR CUP KWA DEPUY INTL., LTD. - 8010379 2294232

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention